First National Bank Of Omaha Regeneron Pharmaceuticals, Inc. Transaction History

First National Bank Of Omaha

$1.43 Billion
Q2 2024

A detailed history of First National Bank Of Omaha transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, First National Bank Of Omaha holds 293 shares of REGN stock, worth $241,572. This represents 0.02% of its overall portfolio holdings.

Number of Shares

293

Previous 355 17.46%

Holding current value

$241,572

Previous $341,000 9.97%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$883.2 - $1071.19 $54,758 - $66,413	-62 Reduced 17.46%	293 $307,000
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $68,604 - $75,494	-76 Reduced 17.63%	355 $341,000
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $73,642 - $83,761	-95 Reduced 18.06%	431 $378,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $409,237 - $499,022	-591 Reduced 52.91%	526 $432,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $3.07 Million - $3.64 Million	-4,389 Reduced 79.71%	1,117 $802,000
Q1 2023 May 03, 2023	SELL	$680.49 - $826.97 $172,844 - $210,050	-254 Reduced 4.41%	5,506 $4.52 Million
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $983,304 - $1.07 Million	-1,393 Reduced 19.47%	5,760 $4.16 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $173,338 - $218,744	-302 Reduced 4.05%	7,153 $4.93 Million
Q2 2022 Sep 06, 2022	SELL	$548.35 - $738.84 $186,439 - $251,205	-340 Reduced 4.36%	7,455 $4.41 Million
Q1 2022 May 25, 2022	SELL	$595.12 - $698.43 $7,736 - $9,079	-13 Reduced 0.17%	7,795 $5.44 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $68,478 - $84,542	-126 Reduced 1.59%	7,808 $4.93 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $1.11 Million - $1.31 Million	-1,926 Reduced 19.53%	7,934 $4.8 Million
Q1 2021 May 06, 2021	BUY	$446.73 - $548.2 $609,786 - $748,293	1,365 Added 16.07%	9,860 $4.67 Million
Q4 2020 Feb 18, 2021	BUY	$478.3 - $607.98 $76,528 - $97,276	160 Added 1.92%	8,495 $4.1 Million
Q3 2020 Nov 06, 2020	SELL	$544.75 - $658.21 $93,152 - $112,553	-171 Reduced 2.01%	8,335 $4.67 Million
Q2 2020 Aug 05, 2020	SELL	$493.32 - $643.92 $641,316 - $837,096	-1,300 Reduced 13.26%	8,506 $5.31 Million
Q1 2020 Apr 29, 2020	SELL	$336.18 - $494.43 $569,488 - $837,564	-1,694 Reduced 14.73%	9,806 $4.79 Million
Q4 2019 Jan 17, 2020	BUY	$274.13 - $376.51 $3.15 Million - $4.33 Million	11,500 New	11,500 $4.32 Million

Others Institutions Holding REGN

# of Institutions

1,492

Shares Held

85.8M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.

Account

First National Bank Of Omaha Regeneron Pharmaceuticals, Inc. Transaction History